Dailypharm Live Search Close

Cherry Huang to succeed Jenny Zheng as head of Janssen Korea

By Eo, Yun-Ho | translator Alice Kang

21.05.06 17:43:36

°¡³ª´Ù¶ó 0
Currently CFO of Janssen Asia Pacific¡¦ appointment effective from June

KPRIA appoints CEO Hye-young Lee as BOD member after Jenny Zheng


Janssen will continue to have a foreign leader head its Korean subsidiary.

According to industry sources, Janssen Korea has appointed Cherry Huang as the next CEO of Janssen Korea to take Jenny Zhuang¡¯s place after Zhuang¡¯s term ends in April. Cherry Huang, who is currently the CFO of Janssen Asia Pacific, will be leading Janssen Korea from June this year.

Hwang had served over 20 years in Johnson & Johnson since 1997 and has held various finance roles within the company. She had built her career in finance in various regions including in the Southeast Asian cluster, China, and Singapore.

With Jenny Zhuang¡¯s transfer, the board of directors (BOD) of the Korean Research-

Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)